Ramón Adell
unknownMale0.0Global Dominance: 0.00%
Ramón Adell has stepped down from the board of Oryzon Genomics, having previously contributed to the company’s strategic direction during a pivotal time of growth.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Ramón Adell is set to leave the Oryzon board.
Oryzon duplica su valor en Bolsa desde enero con sus últimos avances en tratamientos en psiquiatría | EmpresasEl País·
Spain· 2025-02-24
Spain· 2025-02-24
